AtroCore AtroPIM Product Series Overview cross site scripting
Key facts
- Attack vector
- Network
- Privileges required
- None
- User interaction
- Required
- Attack complexity
- Low
- Impact type
- Cross-site scripting
- Confidentiality · integrity · availability
- Low · Low · None
- Fix status
- No fix listed
Attack profile from CVSS 3.1 · NVD. Fix status from CNA. Impact type from CWE-79.
Summary
A vulnerability, which was classified as problematic, was found in AtroCore AtroPIM 1.8.4. This affects an unknown part of the file /#ProductSerie/view/ of the component Product Series Overview. The manipulation leads to cross site scripting. It is possible to initiate the attack remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-251481 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
Why it matters now
SSVC decision points
CISA ADP · SSVC 2.0.3
- Exploitation
- None
- Automatable
- No
- Technical impact
- Partial
The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.
Affected products
Remediation
No fixed version listed by the sources yet.
Timeline
- 2026-10-02 Threatist record created from CVE-2024-0696
- 2026-10-03 Alias added: GHSA-x3fc-2j7c-7xqp
References
More AtroCore Atropim vulnerabilities
- TI-2023-11850 Atropim 1.5.26 is vulnerable to Directory Traversal. CVSS 3.1HIGH 7.5
Sources
- CVE-2024-0696 · CVE Program
- CVE-2024-0696 · NVD
- FIRST EPSS
- GHSA-x3fc-2j7c-7xqp · GitHub Advisory Database · CC BY 4.0
This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences